New lotIn stockGLP-1 / GIP / Glucagon agonist
Compounded retatrutide
Triple-incretin investigational peptide. Lyophilized, sealed under argon.
- Dose
- 10 mg
- Purity
- 99.4%
- MW
- 4677.5
- Lot
- EV-024-R
$420/ vial
Research-grade peptides · Lot-traceable
Precision peptides, for the people doing the work.
Pharmaceutical-grade compounds with mass-spec validation, sealed chain-of-custody, and the documentation your protocol requires. No theatre. Just clean reagents and clear paperwork.
Lot · EV-024-Revé · compounded retatrutide · Rx only
Independent third-party assaySealed chain of custody21 CFR documentedMass-spec validatedU.S. lab synthesis
01Catalog
Six compounds in active rotation. New lots most weeks.
Each compound is synthesized in our U.S. facility, validated against reference standards, and released only with a signed COA.
New lotIn stockproduct shot · tirzepatideRestockedLow · 4 left
GLP-1 / GIP dual agonist
Compounded tirzepatide
Long-acting incretin. Reconstitute in 1ml bacteriostatic water.
- Dose
- 15 mg
- Purity
- 99.2%
- MW
- 4813.5
- Lot
- EV-019-T
$340/ vial
product shot · semaglutideIn stock
GLP-1 agonist
Compounded semaglutide
Long-acting GLP-1 analog. Stable 24 months at -20°C.
- Dose
- 5 mg
- Purity
- 99.6%
- MW
- 4113.6
- Lot
- EV-031-S
$185/ vial
02Quality
Three checks between the synthesizer and the seal.
Every vial leaves the lab with a documented chain of custody. No batch ships without independent verification.
01Synthesis
Solid-phase peptide synthesis, in-house.
Compounds are produced in our DEA-licensed U.S. facility using Fmoc-SPPS on a controlled resin. No outsourcing, no overseas intermediates.
100%U.S. synthesized
02Assay
HPLC purity. Mass-spec identity.
Each lot is run on reverse-phase HPLC against a reference standard and confirmed by ESI-MS. Endotoxin and residual solvent are quantified.
≥ 99.2%Avg. lot purity
03Release
Signed COA. Sealed shipment.
Lots are lyophilized, sealed under argon, and shipped with a numbered, institution-addressed certificate of analysis. Cold-chain monitored.
24 mo.Stability at -20°C
Compound of the month · 04 / 26
Compounded retatrutide, 10mg.
A triple-incretin investigational peptide. Eli Lilly’s LY3437943 synthesized to research grade, lyophilized, sealed under argon, and released with a full chromatographic trace.
ClassGLP-1 / GIP / Glucagon triple agonist
Molecular weight4,677.5 g/mol
Sequence length39 residues · C₂₂₀H₃₅₄N₅₆O₇₀
Storage-20 °C lyophilized · 4 °C reconstituted (14 d)
Purity (lot EV-024-R)99.4% by HPLC · < 0.5 EU/mg endotoxin
Reconstitution1.0 mL bacteriostatic water · 10 mg/mL
03Lot ledger
Every lot, on the record.
Public release log of the last six lots. Each row links to the signed certificate of analysis, with HPLC and mass-spec traces attached.
LotCompoundReleasedMWPurityStatusCOA
Showing 6 of 184 lots · 2024 – present
Cited or referenced in
Cell Reports Medicine2025
J. Endocrinol. Invest.2025
Diabetes Care2024
Lancet Diabetes & Endo.2024